SIRT1 and myocardial infarction: Yang et al. found that SUV39H1 deficiency or SUVH39H1 inhibition alleviates cardiac ischemic injury, limits MI size, promotes the survival of mice after MI, reduces cardiomyocyte death, and improves left ventricular function in a SIRT1-dependent manner [56].